drugset / Trial / NCT00678795
A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
The purpose of this study is to evaluate the efficacy of Sativex® compared with placebo in reducing the daily number of episodes on incontinence.
Timeline
- Start
- 2002-08
- Primary completion
- 2005-10
- Completion
- 2005-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nabiximols | Other / unclassified | 25 mg/ml | Other |
| Subject | Nabiximols | Other / unclassified | 27 mg/ml | Other |